Brain-derived neurotrophic factor but not beta-secretase 1, vascular endothelial growth factor, glial fibrillary acidic protein and interleukin-1β correlate with cognitive impairment in adult persons with epilepsy: a cross-sectional single-center study from India

Brain-derived neurotrophic factor but not beta-secretase 1, vascular endothelial growth factor, glial fibrillary acidic protein and interleukin-1β correlate with cognitive impairment in adult persons with epilepsy: a cross-sectional single-center study from India

ObjectivesThis study aims to evaluate cognitive impairment utilizing the Montreal Cognitive Assessment (MoCA) scale, while also exploring the correlation between cognitive impairment and various serum biomarkers, including Brain-derived neurotrophic factor (BDNF), Beta Secretase-1 (BACE1), Vascular...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kamini Bhavsar, Manjari Tripathi, Jyotirmoy Banerjee, Arpna Srivastava, Nidhi, Shivam Pandey, Divya Vohora
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Neurology
Subjects:	Montreal Cognitive Assessment (MoCA) brain-derived neurotrophic factor beta secretase-1 vascular endothelial growth factor glial fibrillary acidic protein interleukin-1β
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1540915/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Survival and Axonal Regeneration of Retinal Ganglion Cells in a Mouse Optic Nerve Crush Model After a Cell-Based Intravitreal Co-Administration of Ciliary Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor at Different Post-Lesion Time Points
by: Yue Hu, et al.
Published: (2025-04-01)

The Causal Relationship Between Neurotrophic Factors and Delirium: A Mendelian Randomization Study
by: Han Wu, et al.
Published: (2025-05-01)

A case of glial fibrillary acidotic protein (GFAP) meningoencephalitis with rheumatoid arthritis
by: Mehri Salari, et al.
Published: (2023-03-01)

Lifestyle and Clinical Predictors of Glial Cell Line-Derived Neurotrophic Factor Expression in Lumbosacral Stenosis-Related Ligamentum Flavum Degeneration
by: Dawid Sobański, et al.
Published: (2025-06-01)

Predicting ICU Admission in Patients with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
by: Su XH, et al.
Published: (2025-08-01)

Glial cell line-derived neurotrophic factor in patients with age-related cataract
by: A.A. Shpak, et al.
Published: (2022-09-01)

Glial Fibrillary Acidic Protein’s Usefulness as an Astrocyte Biomarker Using the Fully Automated LUMIPULSE<sup>®</sup> System
by: Jo Kamada, et al.
Published: (2024-11-01)

Neurotrophic factors in patients with primary open-angle glaucoma and age-related cataract. Part 3. Glial-derived neurotrophic factor
by: A.A. Troshina, et al.
Published: (2022-12-01)

Serum Glial Fibrillary Acidic Protein and S100B Profiles in Severity and Outcome Assessment of Moderate and Severe Head Injury Patients in India
by: Arpana Singh, et al.
Published: (2024-10-01)

Glial cell line-derived neurotrophic factor and its role in attenuating renal fibrosis: a review
by: Yousuf Abdulkarim Waheed, et al.
Published: (2025-03-01)

Case Reports: Three cases of autoimmune glial fibrillary acidic protein astrocytosis in disguise
by: Wen Zhao, et al.
Published: (2025-07-01)

A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's
by: Natalia E. Owen, et al.
Published: (2025-06-01)

Liraglutide improves cognition function in streptozotocin-induced diabetic rats by downregulating β-secretase and γ-secretase and alleviating oxidative stress in HT-22 cells
by: Lou-yan Ma, et al.
Published: (2025-03-01)

Bridging neuro-biomarkers and MR imaging: The synergistic role of glial fibrillary acidic protein in early CNS disease diagnosis
by: Mohammad Ghaderian, et al.
Published: (2025-06-01)

Preliminary Evaluation of the Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries with Glial Fibrillary Acidic Protein
by: Mira Keski-Pukkila, et al.
Published: (2024-11-01)

LEVELS OF GLIAL FIBRILLARY ACIDIC PROTEIN IN SERUM AFTER CEREBRAL ISCHEMIA IN THE NEONATAL PERIOD
by: D. V. Blinov
Published: (2016-06-01)

A single-center retrospective analysis of autoimmune glial fibrillary acidic protein astrocytopathy with seizures in children
by: Hongjun Fang, et al.
Published: (2025-06-01)

Neurotrophic Factors in Multiple Sclerosis: a Review of the Mechanism
by: Samaneh Azizpour, et al.
Published: (2025-01-01)

Clinical analysis and case series report on autoimmune glial fibrillary acidic protein astrocytopathy presenting with autonomic dysfunction
by: Xiao Ke Wu, et al.
Published: (2025-01-01)

Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders
by: Udit Sheth, et al.
Published: (2025-03-01)

Exploring the diversity of biological processes regulated by glial cell line-derived neurotrophic factor, a pleiotropic molecule with therapeutic potential
by: Cristina Porcari, et al.
Published: (2025-06-01)

Serum levels of neurofilament light chain and glial fibrillary acidic protein correlate with disease severity in patients with West Nile virus infection
by: Alessandro Dinoto, et al.
Published: (2025-12-01)

Autoimmune glial fibrillary acidic protein astrocytopathy misdiagnosed as intracranial infectious diseases: case reports and literature review
by: Runhua Bai, et al.
Published: (2025-01-01)

Plasma concentrations of neurofilament light, p-Tau231 and glial fibrillary acidic protein are elevated in patients with chronic kidney disease and correlate with measured glomerular filtration rate
by: Torunn Axelsson, et al.
Published: (2025-05-01)

The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: Advancing clinical applications.
by: Sara Samadzadeh, et al.
Published: (2025-03-01)

Prospective Validation of Glial Fibrillary Acidic Protein, d‐Dimer, and Clinical Scales for Acute Large‐Vessel Occlusion Ischemic Stroke Detection
by: Yasir Durrani, et al.
Published: (2024-07-01)

Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis
by: Xiaomeng Li, et al.
Published: (2024-12-01)

Inactivation of γ‐secretases leads to accumulation of substrates and non‐Alzheimer neurodegeneration
by: Hermien Acx, et al.
Published: (2017-06-01)

Nasal Glial Heterotopia: An Unusual Cause of Lump on the Nose in a Child- A Case Report
by: Suchitra Pusapati, et al.
Published: (2025-01-01)

Exploring the effects of moxibustion on cognitive function in rats with multiple cerebral infarctions from the perspective of glial vascular unit repairing
by: Jingji Wang, et al.
Published: (2024-10-01)

Auto-Immune Glial Fibrillary Acidic Protein Astrocytopathy with Active Intrathecal Epstein-Barr Virus: A Single-Center Case Series Report
by: Yu X, et al.
Published: (2025-05-01)

Endogenous γ-Secretase Is Linked to Phagocytic Activity in Microglial Cells
by: Emily Williams, et al.
Published: (2025-05-01)

Serum glial fibrillary acidic protein and protein gene product 9.5 for predicting neurological outcomes in cardiac arrest patients with cortical response to somatosensory evoked potentials
by: Chenchen Hang, et al.
Published: (2025-05-01)

The role of neurotrophic growth factors in the pathophysiology of bronchial asthma associated with obesity
by: O. Yu. Kytikova, et al.
Published: (2021-04-01)

γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct
by: Yong Ran, et al.
Published: (2017-05-01)

Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury
by: Tyler L. Borko, et al.
Published: (2025-05-01)

Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis
by: Gabriel Sauvage, et al.
Published: (2025-03-01)

Increased Plasma β‐Secretase 1 Activity Correlates With Neurodegeneration in Cerebral Small Vessel Disease
by: Ya Su, et al.
Published: (2024-12-01)

Brain derived neurotrophic factor and secreted amyloid precursor protein‐α response to moderate and high intensity exercise
by: Felicity S. E. Spencer, et al.
Published: (2025-05-01)

Brain-derived neurotrophic factor and coronary artery disease
by: Oksana Yu. Kytikova, et al.
Published: (2022-06-01)